MedPath

Megainpharm GmbH

Ownership
Private
Employees
-
Market Cap
-
Website

A Clinical Trial Investigating the Short-term Relief of Symptoms of Acute Pharyngitis by Treatment With Three Different Doses of MYRAMISTIN™ Oromucosal Spray

Phase 2
Terminated
Conditions
Acute Pharyngitis
Interventions
First Posted Date
2020-07-14
Last Posted Date
2022-05-05
Lead Sponsor
Megainpharm GmbH
Target Recruit Count
170
Registration Number
NCT04470089
Locations
🇩🇪

Practive, Berlin, Germany

🇦🇹

MUW, Wien, Austria

🇦🇹

Zentrum für Klinische Studien, Wien, Austria

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath